Company overview
Takara Bio provides kits, reagents, instruments, and services for life science research in gene discovery, regulation, function, cancer therapy, NGS, and single-cell technologies. The company offers CDMO services for regenerative medicine, including GMP manufacturing for cellular and gene therapy products at facilities in Japan, the US, Europe, China, and India. Their portfolio supports applications like CAR-T therapy, immune profiling, vaccine development, and drug discovery.
Takara Bio—Home is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents, CDMO & Manufacturing partner serving United States & Americas. Core focus areas include takara bio, gene therapy cdmo, ngs reagents, single-cell sequencing, gmp manufacturing.
Industry categories: Life Science Reagents, CDMO & Manufacturing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.takarabio.com
- Categories
- Life Science Reagents, CDMO & Manufacturing
- Markets served
- United States & Americas
- Keywords
- takara bio, gene therapy cdmo, ngs reagents, single-cell sequencing, gmp manufacturing
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What manufacturing capabilities does Takara Bio offer for cell and gene therapy?
- Takara Bio provides comprehensive GMP manufacturing and quality-testing services for cellular and gene therapy products at facilities like the Center for Gene and Cell Processing in Japan and GMP stem cell facilities in Sweden.
- What geographic regions does Takara Bio serve?
- Takara Bio operates manufacturing centers in the US, Europe, China, and India, with a global sales network supporting customers inside and outside Japan, including Europe, Middle East, and Africa.
- Does Takara Bio support regulatory-compliant production?
- Yes, Takara Bio offers GMP-grade manufacturing at facilities in Japan and Sweden, along with certified service providers for NGS and single-cell technologies to advance research and development.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
